(Q51559556)

7 April 2018

title

Folic acid improves arterial endothelial function in adults with hyperhomocystinemia. (English)

1 reference

7 April 2018

0 references

1 reference

1 reference

1 reference

Woo KS

1

1 reference

7 April 2018

Chook P

2

1 reference

7 April 2018

Lolin YI

3

1 reference

7 April 2018

Sanderson JE

4

1 reference

7 April 2018

Metreweli C

5

1 reference

7 April 2018

Celermajer DS

6

1 reference

7 April 2018

language of work or name

English

0 references

publication date

1 December 1999

1 reference

7 April 2018

Journal of the American College of Cardiology

published in

1 reference

7 April 2018

volume

34

1 reference

7 April 2018

page(s)

2002-2006

1 reference

7 April 2018

issue

7

1 reference

7 April 2018

https://api.unpaywall.org/v2/10.1016/s0735-1097(99)00469-6?email=unpaywall_01@example.com

1 reference

19 March 2024

access restriction status

open access

1 reference

inferred from online access status

cites work

Hyperhomocyst(e)inemia. A common and easily reversible risk factor for occlusive atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900469-6

7 January 2021

Homocysteine and coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900469-6

7 January 2021

Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900469-6

7 January 2021

Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900469-6

7 January 2021

Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900469-6

7 January 2021

Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900469-6

7 January 2021

The pathogenesis of atherosclerosis: a perspective for the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900469-6

7 January 2021

Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900469-6

7 January 2021

Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900469-6

7 January 2021

Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900469-6

7 January 2021

Close relation of endothelial function in the human coronary and peripheral circulations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900469-6

7 January 2021

Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900469-6

7 January 2021

A sharper Bonferroni procedure for multiple tests of significance

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900469-6

7 January 2021

Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900469-6

7 January 2021

Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900469-6

7 January 2021

Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900469-6

7 January 2021

Is NO an endogenous antiatherogenic molecule?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900469-6

7 January 2021

The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900469-6

7 January 2021

Plasma homocysteine in acute myocardial infarction: homocysteine-lowering effect of folic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900469-6

7 January 2021

The role of vitamins in the pathogenesis and treatment of hyperhomocyst(e)inaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900469-6

7 January 2021

5-Methyltetrahydrofolate, the Active Form of Folic Acid, Restores Endothelial Function in Familial Hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900469-6

7 January 2021

Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900469-6

7 January 2021

Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900469-6

7 January 2021

Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900469-6

7 January 2021

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900469-6

7 January 2021

10.1016/S0735-1097(99)00469-6

Identifiers

DOI

1 reference

7 April 2018

PubMed ID

10588216

1 reference

7 April 2018